Congresswoman Ros-Lehtinen to Join President Shalala, Members of University of Miami Faculty and Staff for Exciting Announcement

Congresswoman Ros-Lehtinen to Join President Shalala, Members of University of Miami Faculty and Staff for Exciting Announcement

MONDAY IN MIAMI: Congresswoman Ros-Lehtinen will join University of Miami President Donna Shalala, Dean Pascal J. Goldschmidt of the University of Miami Leonard M. Miller School of Medicine, and Dr. Jose Szapocznik, Chair of University of Miami’s Department of Epidemiology and Public Health for a news conference at the University’s Life Science & Technology Park for a major announcement.

Miami, Florida – Congresswoman Ileana Ros-Lehtinen (R-FL) will join members of the faculty and staff of the University of Miami for a news conference this coming Monday, September 10th, where they will announce the inclusion of the University of Miami’s Clinical and Translational Science Institute  (CTSI)  into the National Institutes of Health’s (NIH) prestigious Clinical and Translational Science Awards (CTSA) Consortium. University of Miami’s CTSI will join 60 other medical research institutions from across the nation as they work together translating research discovery into improved patient care.

WHAT:           University of Miami news conference to announce and discuss the University of Miami’s CTSI’s addition to the NIH’s prestigious CTSA Consortium.

WHEN:          MONDAY September 10, 2012 at 11:00 a.m.

WHERE:        University of Miami Life Science & Technology Park - 1951 NW 7th Avenue, Miami, FL

Said Ros-Lehtinen: “This is such a tremendous achievement. The University of Miami is a wonderful and deserving addition to the NIH’s prestigious Clinical and Translational Science Awards Consortium. It has a proven academic and research record, and has been dedicated to making significant contributions to the health of South Florida’s diverse population. The outstanding faculty, staff and bright young students of the university are certain to further the Consortium’s goal of translating emerging medical research and discoveries into effective methods of treating communities, and will certainly bring a unique approach to the Consortium through their contributions to minority health.”

###